LivaNova PLC cotiza a 76.43 USD y tiene una capitalización bursátil de $4.2B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotra…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $1.26 | $0.98 | $0.86 |
| Estimado | $1.06 | $1.09 | $0.90 | $0.81 |
| Sorpresa | — | +15.6% | +8.9% | +6.2% |
| Métrica | LIVN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 67.7% | 57.0% | +10.7% |
| Operating Margin | 14.4% | -38.6% | +53.0% |
| Net Margin | -17.5% | -33.6% | +16.1% |
| FCF Margin | 12.5% | -13.9% | +26.3% |
| ROE | -20.2% | -40.4% | +20.2% |
| ROA | -9.3% | -32.0% | +22.7% |
| Current Ratio | 1.36 | 2.84 | -1.48 |
| Debt / Equity | 0.31 | 0.28 | +0.03 |